Articles from BIOTECH Patent News (February 1, 2003)

1-42 out of 42 article(s)

Title	Type	Words
Alnylam licenses RNA interference patents.		376
Alnylam licenses RNA interference patents.		376
Applied Tissue Technologies obtains United States patent.	Brief Article	150
Bayer obtains United States patent.	Brief Article	235
BioStratum and DakoCytomation form cancer agreement.		596
Boehringer Ingelheim obtains United States patent.	Brief Article	195
Calgene obtains United States patent.	Brief Article	84
Celgene expands kinase patent estate.		457
Demegen receives patent for method of treating HIV.	Brief Article	177
diaDexus exclusively licenses rights related to Testisin.	Brief Article	144
diaDexus exclusively licenses rights related to Testisin.		144
Exelixis obtains United States patent.	Brief Article	93
Genaissance Pharma adds asthma patents to patent estate.	Brief Article	267
Genaissance Pharma adds asthma patents to patent estate.	Brief Article	267
GPC Biotech licenses reverse genomics technology from ARIAD.		387
Haemacure obtains United States patent for a fibrin-based biomaterial adhesive.	Brief Article	221
Ingenium signs INGENOtyping agreement with SEQUENOM.		414
Ingenium signs INGENOtyping agreement with SEQUENOM.		414
Lexicon discovers target for osteoporosis.		591
Lysosomal enzyme patent expands Transkaryotic patent position.		375
National Institute of Agrobiological Sciences obtains United States patent.	Brief Article	195
Nisshin Flour obtains United States patent.	Brief Article	96
Novo Nordisk obtains United States patent.	Brief Article	82
Oklahoma Medical Research Foundation obtains United States patent.	Brief Article	85
Patent issued for Introgen's cancer therapeutic.		543
Peregrine receives endothelial growth factor patents.		554
Phairson Medical obtains United States patent.	Brief Article	114
Pharmacopeia achieves milestone in collaboration with Berlex.		338
Pharmacopeia achieves milestone in collaboration with Berlex.		338
Praxis Pharmaceuticals signs major developmental agreement.		514
Ribapharm responds to recent ribavirin patent litigation.	Brief Article	258
Schering-Plough settles hepatitis C patent litigation with Three Rivers.	Brief Article	251
ScienceBased patents dry eye product.		355
Scripps Research Institute obtains United States patent.	Brief Article	150
Sepracor awarded patents for insomnia treatment.		483
Sepracor awarded patents for insomnia treatment.		483
Stressgen granted United States patent covering heat shock protein HspE7.		476
SuperGen issued patent covering injectable camptothecin.	Brief Article	172
TheRyte Limited obtains United States patent.	Brief Article	104
University of Nebraska obtains United States patent.		116
Valentis licenses PEGylation technology.		328
Valentis licenses PEGylation technology.		328